Amdocs’ 2027 Outlook Exposes Customer Concentration

November 4, 2026 | Robert Young

Amdocs entered fiscal 2027 with a customer-concentration problem large enough to reshape its revenue, earnings and cash-flow outlook. The company expects reported revenue to fall 14.3% to 17.9% and non-GAAP diluted earnings per share to decline 26% to 30%, incorporating its best estimates for a legal dispute with T-Mobile and the possible termination of agreements between the companies.

The judgment

• Implication: Customer concentration has moved from a disclosed risk to an operating-plan constraint, making cash preservation and replacement-revenue quality more important than near-term EPS support.
• What would change the conclusion: Resolution of the dispute on economically durable terms or signed replacement business that produces comparable recurring cash flow without excessive acquisition or transition spending.
• Management action: Report a concentration bridge showing revenue, backlog, free cash flow and transition costs with and without the affected customer.

A strong year ended with a weaker base

Amdocs reported fiscal 2026 revenue of $4.697 billion, up 3.6%, and non-GAAP diluted EPS of $7.41, up 6%. Free cash flow was $562 million after $167 million of restructuring payments; excluding those payments, the company said free cash flow would have been $729 million.

The twelve-month backlog was $3.50 billion. On a pro forma basis that adjusts for exited businesses, backlog declined 9.6% year over year and about $370 million sequentially. That makes the backlog composition and conversion rate more informative than the headline total.

Guidance now includes a dispute scenario

Amdocs said it and T-Mobile have exchanged notices alleging material breaches and threatening termination or monetary relief, including arbitration. Management explicitly incorporated its current estimates of those circumstances into fiscal 2027 guidance, including a case in which either party terminates the agreements.

The company expects fiscal 2027 free cash flow of $440 million to $500 million. It also acquired insurance-software provider EIS for about $340 million in cash, with potential additional consideration, and secured $500 million of term loans in October. These decisions increase the importance of separating organic replacement revenue from acquired growth.

Cash allocation must follow the new risk

Amdocs said it expects to return a majority of fiscal 2027 free cash flow to shareholders, while slowing repurchases and supporting investment. That policy may remain affordable, but the business is entering a transition with lower earnings, a major customer dispute, restructuring payments and acquisition integration.

• Scenario ownership: assign management triggers for dispute resolution, contract termination and replacement wins.
• Liquidity protection: show free cash flow before restructuring and acquisition-related cash costs.
• Concentration reduction: report how much new backlog comes from customers outside the largest relationships.
• Capital returns: make repurchase pace responsive to cash conversion and leverage, not only dividend or EPS objectives.

The central issue is not whether Amdocs can sign new contracts. It is whether new work replaces the economics, duration and cash profile of concentrated revenue quickly enough to protect the balance sheet during the transition.

For related analysis, see CCC debt and the refinancing gap and Big Tech’s capital spending versus operating cash flow. The free 13-week cash-flow forecast template can support downside scenarios and decision triggers.

Sources and evidence

• Amdocs, fourth-quarter and fiscal 2026 results, November 3, 2026.
• Amdocs earnings-call transcript, November 3, 2026.

Company results, dispute disclosures and guidance are reported facts or management estimates. The concentration and capital-allocation conclusions are Numbers & Judgment analysis.